Transcatheter aortic valve implantation: Revolution and evolution 10 years on

Heart

Volumn 98, Issue SUPPL. 4, 2012, Pages

  Myat, Aung ^a   Hildick Smith, David ^b   Young, Christopher ^a   Thomas, Martyn ^a   Redwood, Simon R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE KIDNEY FAILURE; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; MINIMALLY INVASIVE PROCEDURE; MITRAL VALVE REGURGITATION; MORTALITY; NONHUMAN; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SCORING SYSTEM; THROMBOEMBOLISM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FORECASTING; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE;

EID: 84869065887     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-303110     Document Type: Editorial

References (62)

1. Serruys P, Morice M, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
2. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.
3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
4. Kodali S, Williams M, Smith C, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366:1686-95.
5. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704.
6. Vahanian A, Alfieri O, Andreotti F, et al. Gudelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
7. Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012;98 (Suppl 4): iv7-13.
8. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011;8:162-72.
9. Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease - 2011 update. Circulation 2011;124:1783-91.
10. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-56.
11. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calci fic aortic stenosis. N Engl J Med 2005;352:2389-97.
12. Chan KL, Teo K, Dumesnil JG, et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14.
13. Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding core valve prosthesis. Eur Heart J 2012;33(8):969-76.
14. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.
15. Naber CK, Prendergast B, Thomas M, et al. An interdisciplinary debate initiated by the European Society of Cardiology working group on Valvular Heart Disease. EuroIntervention 2012;7:1257-74.
16. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
17. Wendler O, Walther T, Nataf P, et al. Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg 2010;38:119-27.
18. Afilalo J, Mottillo S, Eisenberg MJ, et al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes 2012;5:222-8.
19. Lee DH, Buth KJ, Martin B-J, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation 2010;121:973-8.
20. Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
21. Van Mieghem NM, Head SJ, van der Boon RMA, et al. The SURTAVI model: proposal for a pragmatic risk strati fication for patients with severe aortic stenosis. EuroIntervention 2012;8(2):258-66.
22. Grant SW, Hickey GL, Dimarakis I, et al. How does EuroSCORE II perform in UK cardiac surgery; an analysis of 23 740 patients from the society for cardiothoracic surgery in Great Britain and Ireland national database. Heart 2012;98:1568-72.
23. Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734-44; discussion 744-5.
24. Himbert D, Iung B, Attias D, et al. Predictive factors of mid-term mortality after transcatheter aortic valve implantation. Eur Heart J Suppl 2010;31:956-7.
25. Holmes DR, Mack MJ. Transcatheter valve therapy a professional society overview from the american college of cardiology foundation and the society of thoracic surgeons. J Am Coll Cardiol 2012;58(4): 445-55.
26. Rajani R, Hancock J, Chambers JB. The art of assessing aortic stenosis. Heart 2012;98(Suppl 4): iv14-22.
27. Chin D. Echocardiography for transcatheter aortic valve implantation. Eur J Echocardiogr 2009;10:i21-9.
28. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Coronary Interventions (EAPCI). Eur Heart J 2008; 29:1463-70.
29. Holmes DR, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:1200-54.
30. Delgado V, Kapadia S, Schalij MJ, et al. Transcatheter aortic valve implantation: implications of multimodality imaging in patient selection, procedural guidance, and outcomes. Heart 2012;98:743-54.
31. Walther T, Blumenstein J, van Linden A, et al. Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. Heart 2012:98(Suppl 4):iv23-29.
32. Piazza N, Otten A, Schultz C, et al. Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System. Heart 2010;96: 19-26.
33. Lange R, Bleiziffer S, Mazzitelli D, et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol 2012;59:280-7.
34. Bonhoeffer P, Boudjemline Y, Saliba Z. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-5.
35. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113: 842-50.
36. Bruschi G, Fratto P, De Marco F, et al. The trans-subclavian retrograde approach for transcatheter aortic valve replacement: single-center experience. J Thorac Cardiovasc Surg 2010;140:911-15; 915.e1-2.
37. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591-6.
38. Bapat V, Thomas M, Hancock J, et al. First successful trans-catheter aortic valve implantation through ascending aorta using Edwards SAPIEN THV system. Eur J Cardiothorac Surg 2010;38:811-13.
39. Binder RK, Webb JG. TAVI: from home-made prosthesis to global interventional phenomenon. Heart 2012;98(Suppl 4):iv30-36.
40. Prendergast BD, Naber CK, Popma JJ. Transatlantic perspective on TAVI: from essential infrastructure and integration to expansion, research and development. Heart 2012;98(Suppl 4):iv37- 43.
41. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. J Am Coll Cardiol 2011;57 :253-69.
42. Kappetein AP, Head SJ, Généreux P, et al. Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). J Am Coll Cardiol 2012;60:1438-54.
43. Stortecky S, Buellesfeld L, Wenaweser P, et al. Transcatheter aortic valve implantation: the procedure. Heart 2012:98(Suppl 4):iv44-51.
44. Stortecky S, Buellesfeld L, Wenaweser P, et al. Transcatheter aortic valve implantation: prevention and management of complications. Heart 2012:98 (Suppl 4) :iv52-64.
45. Khawaja MZ, Thomas M, Joshi A, et al. The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 2012 Jun 27. pii: 20120602-02. [Epub ahead of print]
46. Amat-Santos IJ, Rodés-Cabau J, Urena M, et al. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol 2012;59:178-88.
47. Iung B, Himbert D, Vahanian A. Atrial fibrillation following transcatheter aortic valve implantation: do we underestimate its frequency and impact?. J Am Coll Cardiol 2012;59:189-90.
48. Ussia GP, Scarabelli M, Mulè M, et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2011;108:1772-6.
49. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol 2012;60:483-92.
50. Takeda K, Matsumiya G, Sakaguchi T, et al. Impact of untreated mild-to-moderate mitral regurgitation at the time of isolated aortic valve replacement on late adverse outcomes. Eur J Cardiothorac Surg 2010;37:1033-8.
51. Toggweiler S, Boone RH, Rodés-Cabau J, et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol 2012;59:2068-74.
52. Tay ELW, Gurvitch R, Wijesinghe N, et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. J Am Coll Cardiol Intv 2011;4:1290-7.
53. D'Onofrio A, Gasparetto V, Napodano M, et al. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2012; 41:1271-6; discussion 1276-7.
54. Sinning J-M, Werner N, Nickernig C, et al, Transcatheter aortic valve implantation:the evidence. Heart 2012:98(Suppl 4):iv65-72.
55. Mack MJ. Transcatheter aortic valve implantation: changing patient populations and novel indications. Heart 2012:98(Suppl 4):iv73-79.
56. Abdel-Wahab M, Zahn R, Horack M, et al. Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol 2012 Jul 7. [Epub ahead of print]
57. Dewey TM, Brown DL, Herbert, et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010;89:758-67; discussion 767.
58. Ussia GP, Barbanti M, Colombo A, et al. Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry. Int J Cardiol 2012 Mar 27. [Epub ahead of print]
59. Ducrocq G, Al-Attar N, Himbert D, et al. Early and mid-term outcomes in patients undergoing transcatheter aortic valve implantation after previous coronary artery bypass grafting. Eur J Cardiothorac Surg 2012; 41:499-504.
60. Conradi L, Seiffert M, Franzen O, et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 2011; 100 :311-16.
61. Wenaweser P, Pilgrim T, Guerios E, et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2011;7:541-8.
62. Pasic M, Dreysse S, Unbehaun A, et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2012;14: 463-8.